Market Overview

UPDATE: BMO Capital Markets Reiterates Market Perform Rating, Raises PT on IDEX Corporation

Share:
Related IEX
Earnings Scheduled For July 24, 2018
A Preview Of Idex's Q4 Earnings

In a report published Wednesday, BMO Capital Markets reiterated its Market Perform rating on IDEX Corporation (NYSE: IEX), and slightly raised its price target from $43.00 to $44.00.

BMO Capital Markets noted, “IDEX reported 3Q12 adjusted EPS of $0.66, excluding restructuring charges of $0.06. Compared with our model, IDEX reported a slightly lower tax rate, which benefited EPS by $0.01. Adjusting for restructuring charges and a lower tax rate, a comparable EPS is $0.65, slightly above our estimate of $0.64 and the consensus of $0.63. The slightly better-than-expected earnings were a result of higher-than-expected margins in HST and FSD.”

IDEX Corporation closed on Tuesday at $41.50.

Latest Ratings for IEX

DateFirmActionFromTo
Oct 2018Stifel NicolausMaintainsHoldHold
Jul 2018Stifel NicolausMaintainsHoldHold
May 2018BairdMaintainsOutperformOutperform

View More Analyst Ratings for IEX
View the Latest Analyst Ratings

Posted-In: BMO Capital MarketsAnalyst Color Price Target Analyst Ratings

 

Related Articles (IEX)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
NKEOppenheimerUpgrades0.0
SBEvercore ISI GroupUpgrades4.5
PTIRBC CapitalUpgrades0.0
GPSJP MorganDowngrades24.0
GIIIB. Riley FBRUpgrades47.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

UPDATE: Paradigm Capital Lowers PT to $67 on Valeant Pharmaceuticals on Raising Interest Cost

UPDATE: Pareto Securities Downgrades Autoliv to Hold